Use of methylxanthine therapies for the treatment and prevention of apnea of prematurity
K Schoen, T Yu, C Stockmann, MG Spigarelli… - Pediatric Drugs, 2014 - Springer
Apnea of prematurity (AOP) is a common complication of preterm birth, which affects more
than 80% of neonates with a birth weight less than 1,000 g. Methylxanthine therapies …
than 80% of neonates with a birth weight less than 1,000 g. Methylxanthine therapies …